Announced Thu, 17 Sept, 2026 · 20:27 IST

AGM for FY26 extended by 3 months due to Chairperson ill health

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Dr Lalchandani Labs informed BSE that it applied to the Registrar of Companies (ROC) Delhi for an extension to hold its Annual General Meeting for FY 2025-26, originally due by September 30, 2026, citing the ill health of the Chairperson. ROC Delhi has approved the request, granting a 3-month extension under Section 96(1) of the Companies Act, 2013, allowing the AGM to be held by December 31, 2026. The exact date and venue will be communicated later. ROC also cautioned the company to ensure timely compliance in the future.

Likely market impact

Minor administrative delay; AGM postponed to latest by Dec 31, 2026. No direct business impact but signals governance concerns.